Skip to main content
. 2022 Dec 14;23(1):160. doi: 10.1186/s10194-022-01513-w

Table 2.

Migraine Population - Drug Consumption

Variable, n (%) Physician-assigned diagnosis patients
(n = 16,675)
Triptan-prescribed patients
(n = 14,091)
Overall
(n = 30,766)
Triptan 11,973 (71.8%) 14,091 (100.0%) 26,064 (84.7%)
Combination pain drug 6721 (40.3%) 5890 (41.8%) 12,611 (41.0%)
Opioid drug 5302 (31.8%) 4424 (31.4%) 9726 (31.6%)